Tobacco Use Disorder
📧 Sign up to get email alerts when something new happens for Tobacco Use Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: Development of a Mindfulness-Based Treatment for the Reduction of Alcohol Use and Smoking Cessation [NA]
A completed clinical trial tested a mindfulness-based treatment to reduce alcohol use and support smoking cessation. Results have been poste…
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Smoking Cessation for Cervical Cancer Survivors [NA]
Completed clinical trial on smoking cessation interventions for cervical cancer survivors; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-03-20Clinical Trial Update: Mechanisms of Lorcaserin for Smoking Cessation [Phase 2]
Phase 2 trial update on lorcaserin mechanisms for smoking cessation has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: Examining the Effects of Neural Stimulation on Inhibitory Control and Cigarette Smoking [NA]
A completed clinical trial exploring neural stimulation effects on inhibitory control and cigarette smoking in individuals with tobacco use …
-
CLINICAL_TRIALS trial_result · 2023-03-07Clinical Trial Update: Optimizing Smoking Cessation for People With HIV/AIDS Who Smoke [Phase 3]
A Phase 3 trial investigating strategies to optimize smoking cessation in people living with HIV/AIDS has completed, with results posted in …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Effect of a Non-Invasive Brain Stimulation Technique on Smoking Cessation Behaviors [NA]
Clinical trial completed to evaluate a non-invasive brain stimulation technique for smoking cessation behaviors in tobacco use disorder.
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: Behavioral Activation for Smoking Cessation and the Prevention of Post-Cessation Weight Gain [NA]
A completed clinical trial evaluating behavioral activation to support smoking cessation and prevent post-cessation weight gain; results wer…
-
CLINICAL_TRIALS trial_result · 2023-02-14Clinical Trial Update: Text Message Quit Vaping Intervention for Young Adults [NA]
Clinical trial update reporting completion and posted results for a text-message intervention aimed at helping young adults quit vaping and …
-
FDA approval · 2023-02-07FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for Bupropion hydrochloride from Heritage Pharmaceuticals (d/b/a Avet Pharmaceuticals Inc.), rep…
-
CLINICAL_TRIALS trial_result · 2023-01-26Clinical Trial Update: Evaluating the Feasibility and Efficacy of a Real-time Smoking Intervention Using Wearable Technology [NA]
A completed clinical trial evaluating the feasibility and efficacy of real-time smoking intervention using wearable technology for tobacco u…
-
FDA approval · 2023-01-25FDA Approved: VARENICLINE — Original Application (Apotex Corp)
The FDA approved Apotex Corp's generic varenicline under an Original Abbreviated New Drug Application for smoking-cessation use.
-
CLINICAL_TRIALS trial_result · 2023-01-23Clinical Trial Update: Development of a mHealth Intervention for Ambivalent Smokers [Phase 1]
Phase 1 clinical trial update on a mobile health intervention for ambivalent smokers, with completed status and results posted.
-
FDA approval · 2022-12-21FDA Approved: NICOTINE POLACRILEX GUM — Original Application (Fertin Pharma A/S)
FDA approved Fertin Pharma A/S's Nicotine Polacrilex Gum as an original application for the treatment of nicotine dependence and to aid smok…
-
CLINICAL_TRIALS trial_result · 2022-12-07Clinical Trial Update: Project 3, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in People With Current Affective Disorders [Phase 1, Phase 2]
A combined Phase 1/2 trial evaluated extended exposure to low nicotine content cigarettes in adults with tobacco use disorder; the study has…
-
CLINICAL_TRIALS trial_result · 2022-12-01Clinical Trial Update: Project 1, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Childbearing Age Women [Phase 1, Phase 2]
Phase 1/Phase 2 trial evaluating extended exposure to low nicotine content cigarettes in women of childbearing age with tobacco use disorder…
-
CLINICAL_TRIALS trial_result · 2022-12-01Clinical Trial Update: Project 2, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Opioid Abusers [Phase 1, Phase 2]
An early-to-mid stage trial evaluating extended exposure to low-nicotine cigarettes in individuals with tobacco use disorder has completed p…
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: Pivot Breath Sensor Human Factors and Usability Study [NA]
Phase not applicable; completed human factors and usability study for Pivot Breath Sensor with results posted.
-
CLINICAL_TRIALS research · 2022-11-08Clinical Trial Update: Correcting Public Misperceptions About Very Low Nicotine Content Cigarettes [NA]
A completed clinical trial investigating public misperceptions about very low nicotine content cigarettes conducted by UNC Lineberger Compre…
-
CLINICAL_TRIALS trial_result · 2022-10-13Clinical Trial Update: Carbon Monoxide Breath Sensor System Performance, Human Factors, and Usability Assessment Conducted in a Single Visit [NA]
A completed clinical trial evaluating a carbon monoxide breath sensor system's performance, human factors, and usability in a single visit f…
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Families With Substance Use and Psychosis: A Pilot Study [NA]
A completed pilot study from McLean Hospital investigating families with substance use and psychosis; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-09-16Clinical Trial Update: Switching to Very Low Nicotine Content Cigarettes vs Reducing Cigarettes Per Day [Phase 2, Phase 3]
A Phase 2/3 trial compared switching to very low nicotine content cigarettes with reducing cigarettes per day in tobacco use disorder; study…
-
CLINICAL_TRIALS trial_result · 2022-08-16Clinical Trial Update: Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI) [NA]
A completed clinical trial on persistence-targeted smoking cessation in individuals with serious mental illness has posted results as of 202…
-
FDA approval · 2022-06-28FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)
The FDA approved a supplemental application from Granules Pharmaceuticals Inc. to approve a bupropion hydrochloride granule formulation unde…
-
FDA approval · 2022-06-14FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for bupropion hydrochloride from Rising Pharma Holdings, Inc., authorizing the generic product's…
-
CLINICAL_TRIALS trial_result · 2022-06-08Clinical Trial Update: Connecting Alaska Native People to Quit Smoking [NA]
A completed clinical trial investigating interventions to help Alaska Native people quit smoking; results have been posted.